Bioink technology firm BIO INX has partnered with volumetric 3D printing company Readily3D to introduce new biomaterials for volumetric 3D bioprinting.
At the Vienna University of Technology, also known as TU Wien, researchers have taken a step towards creating replacement tissue, which could possibly used to replace injured cartilage, in the lab using 3D printing.
University of Bayreuth has announced that a team from the university, led by Professor Dr Leonid Ionov, has developed a new type of 3D printing technology that combines hydrogels and fibres.
A team of scientists at the University of Wisconsin-Madison (UW-Madison) in the U.S. has developed what is believed to be the first 3D printed brain tissue that can grow and function like typical brain tissue.
The Lithuania-based company has used its FemtoBrush bio printing technology to produce a 2mm tall Christmas tree scaffold to demonstrate the potential for complex, functional 3D printed tissue scaffolds.
Aston University is set to install a Quantum X 3D bioprinter after the Biotechnology and Biological Sciences Research Council (BBSRC) awarded a grant of 612,176 GBP.
Hannover Medical School’s (MHH) ENT clinic has used Desktop Health’s 3D-Bioplotter Manufacturer Series to produce a customised ear implant with drug release benefits.
The University of Oxford has announced that researchers at the institution have developed a ‘breakthrough’ 3D printing technique that it says could one day provide tailored repairs for those who suffer brain injuries.
Five Belgian companies and research centres are joining forces in the AstroCardia project, which will involve a 3D bioprinted heart and circulatory system being sent into space to study heart health and ageing.
Redwire Corporation has announced that its wholly owned subsidiary, Redwire Space NV, has been awarded a 14 million EUR contract under a program funded by the Exploration Programme of the ESA to design, develop, and qualify the 3D-BioSystem Facility.
Stratasys has announced a joint development and commercialisation agreement with CollPlant Biotechnologies focused on the biofabrication of human tissues and organs.
To try and improve patient care on Earth, and develop more effective ways of treating torn tissues, researchers from Redwire Space are turning to the microgravity environment of the International Space Station (ISS) National Laboratory.